Genetic Variant rs1800795 (G>C) in the Interleukin 6 (IL6) Gene and Susceptibility to Coronary Artery Diseases, Type 2 Diabetes, Acute Pancreatitis, Rheumatoid Arthritis, and Bronchial Asthma in Asians: A Comprehensive Meta-Analysis Based on 30154 Subjects
DOI:
https://doi.org/10.47852/bonviewMEDIN42021996Keywords:
rs1800795, meta-analysis, Asian, CAD, rheumatoid arthritisAbstract
Numerous studies conducted globally have explored the possible connection between the IL6 gene variant rs1800795 (G>C) and the risk of several diseases. Nonetheless, the correlation specifically within the Asian population remains inconclusive. Hence, this extensive meta-analysis aims to establish a conclusive correlation between the rs1800795 variant and susceptibility to various diseases among Asians. Fifty eligible articles were chosen from Google Scholar, PubMed, Web of Science, and PMC based on specific inclusion criteria. Odds ratios alongside 95% confidence intervals (CI) were utilized. Additionally, subgroup analysis, publication bias, and sensitivity evaluation were conducted. The analysis, of 14,737 cases and 15,417 controls, showed a notable correlation between the rs1800795 (G>C) single-nucleotide polymorphism and the overall disease susceptibility to all models (p-value <2.5E-05). The ethnicity-specific stratified findings indicated that the C-allele of (C vs. G) model of −174G/C polymorphism expressively elevated the overall disease susceptibility in both East and South Asian populations. The disease-based stratified analyses suggested that the C variant of rs1800795 was related to coronary artery diseases and bronchial asthma (under all models), type 2 diabetes (CG vs. GG), acute pancreatitis (AP) (C vs. G; and CC vs. GG), rheumatoid arthritis (CC+CG vs. GG; CC vs. CG+GG; and C vs. G), and AP (C or CC vs. G or GG respectively). IL6 rs1800795 polymorphism is a highly significant disease risk factor in Asians and can potentially serve as a prognostic biomarker for future disease screening and evaluation.
Received: 3 November 2023 | Revised: 18 December 2023 | Accepted: 31 December 2023
Conflicts of Interest
The authors declare that they have no conflicts of interest to this work.
Data Availability Statement
The data that support this work are available upon reasonable request to the corresponding author.
Downloads
Additional Files
Published
Issue
Section
License
Copyright (c) 2024 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.